tradingkey.logo

BUZZ-Australia's Orthocell climbs to 2-week high as co floats expansion plans

ReutersJan 22, 2025 4:49 AM

Shares of Orthocell OCC.AX rise 15.4% to A$1.500, their highest levels since Jan 6

The regenerative medicine firm says that it plans to enter key markets such as Canada and Thailand, among others, in CY2025

Orthocell recently submitted its USFDA regulatory application for the clearance to distribute its nerve drug Remplir in the $1.6 bln (A$2.55 bln) U.S. market commercially

Co expects approval in March/April 2025

About 3.4 mln shares trade hands, 1.9 times the 30-day average of 1.8 mln

Stock rose 230.5% in 2024

(1 Australian dollar = $0.6266)

(Reporting by Manasi Dasa Sundeep in Bengaluru)

((Manasi.DasaSundeep@thomsonreuters.com;))

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI